• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    LeMaitre Vascular, Inc. - Common Stock (NQ:LMAT)

    100.05 -0.56 (-0.56%)
    Streaming Delayed Price Updated: 12:17 PM EDT, Jul 22, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about LeMaitre Vascular, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 Next >
    News headline image
    1 Cash-Producing Stock Worth Your Attention and 2 Facing Headwinds
    While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient... 
    Via StockStory
    Topics Energy
    News headline image
    1 High-Flying Stock to Target This Week and 2 Facing Headwinds
    Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expecta... 
    Via StockStory
    Topics Initial Public Offering
    News headline image
    1 Russell 2000 Stock with Exciting Potential and 2 We Find Risky
    The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size ... 
    Via StockStory
    Topics Firearms
    LeMaitre Vascular Inc. (NASDAQ:LMAT) Passes the Quality Test with Caviar Cruise Screen ↗
    Via Chartmill
    LeMaitre Vascular Inc (NASDAQ:LMAT): A Quality Investing Candidate Passing All Caviar Cruise Screen Tests ↗
    Via Chartmill
    LeMaitre Vascular (NASDAQ:LMAT) Reports Steady Q1 2026 Results with Earnings Beat and In-Line Revenue ↗
    Via Chartmill
    Topics Earnings
    Minervini Watchlist April 24, 2026 - Before Market Open ↗
    Via Chartmill
    LeMaitre Vascular Inc (NASDAQ:LMAT) Passes Key Quality Investing Screens ↗
    Via Chartmill
    News headline image
    3 of Wall Street’s Favorite Stocks We Find Risky
    The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f... 
    Via StockStory
    Topics Electric Vehicles
    News headline image
    1 Reason to Avoid LMAT and 1 Stock to Buy Instead
    LeMaitre has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 15.5% to $101.53 ... 
    Via StockStory
    Topics Artificial Intelligence Stocks Supply Chain
    News headline image
    Winners And Losers Of Q1: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks
    As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the surgical equipment & consumables - specialty industry, includ... 
    Via StockStory
    Topics Artificial Intelligence Economy
    News headline image
    3 Healthcare Stocks with Open Questions
    Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloade... 
    Via StockStory
    Topics Retirement
    News headline image
    5 Insightful Analyst Questions From LeMaitre’s Q1 Earnings Call
    LeMaitre’s first quarter was marked by double-digit sales growth and significant margin expansion, yet the market responded negatively, reflecting concerns o... 
    Via StockStory
    Topics Earnings
    News headline image
    1 High-Flying Stock with Impressive Fundamentals and 2 We Avoid
    Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expecta... 
    Via StockStory
    News headline image
    LMAT Q1 Deep Dive: Artegraft Expansion and Pricing Drive, Margin Upside Meets Cautious Market
    Medical device company LeMaitre Vascular (NASDAQ:LMAT) met Wall Street’s revenue expectations in Q1 CY2026, with sales up 11.2% year on year to $66.55 millio... 
    Via StockStory
    News headline image
    LeMaitre (NASDAQ:LMAT) Posts Q1 CY2026 Sales In Line With Estimates
    Medical device company LeMaitre Vascular (NASDAQ:LMAT) met Wall Street’s revenue expectations in Q1 CY2026, with sales up 11.2% year on year to $66.55 millio... 
    Via StockStory
    News headline image
    LeMaitre (LMAT) Q1 Earnings Report Preview: What To Look For
    Medical device company LeMaitre Vascular (NASDAQ:LMAT) will be reporting results this Tuesday after market hours. Here’s what you need to know. LeMaitre beat... 
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    3 Hyped Up Stocks Walking a Fine Line
    Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements... 
    Via StockStory
    News headline image
    3 Cash-Heavy Stocks Walking a Fine Line
    A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion o... 
    Via StockStory
    News headline image
    Surgical Equipment & Consumables - Specialty Stocks Q4 Earnings: LeMaitre (NASDAQ:LMAT) Firing on All Cylinders
    As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - spe... 
    Via StockStory
    Topics Artificial Intelligence Economy
    News headline image
    3 Russell 2000 Stocks We Steer Clear Of
    The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However,... 
    Via StockStory
    News headline image
    A LeMaitre Vascular (LMAT) Insider Sold 2,625 Shares for $285K ↗
    This medical device innovator, focused on vascular surgery solutions, reported a notable insider sale amid steady financial performance. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    LeMaitre Vascular Up 30% as Insider Sells $285K in Stock. Here's What Investors Should Know ↗
    LeMaitre Vascular, a specialist in vascular medical devices, reported a notable insider sale amid strong recent share gains. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Artivion, Intuitive Surgical, GE HealthCare, LeMaitre, and Globus Medical Shares Plummet, What You Need To Know
    What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in... 
    Via StockStory
    Topics Government Stocks
    News headline image
    3 Unpopular Stocks We’re Skeptical Of
    Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cord... 
    Via StockStory
    News headline image
    3 Cash-Producing Stocks with Warning Signs
    Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff... 
    Via StockStory
    News headline image
    3 Healthcare Stocks We’re Skeptical Of
    Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from eleva... 
    Via StockStory
    News headline image
    2 Profitable Stocks with Exciting Potential and 1 We Turn Down
    While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi... 
    Via StockStory
    News headline image
    PacBio, Myriad Genetics, LeMaitre, Hims & Hers Health, and GoodRx Shares Are Falling, What You Need To Know
    A number of stocks fell in the afternoon session after a surprisingly hot wholesale inflation report fueled investor concerns about persistent price pressures. The Producer Price Index (PPI), a key... 
    Via StockStory
    Topics Economy Government Stocks
    News headline image
    LeMaitre (LMAT) Stock Trades Up, Here Is Why
    Shares of medical device company LeMaitre Vascular (NASDAQ:LMAT) jumped 16.8% in the morning session after the company reported strong fourth-quarter 2025 results that surpassed Wall Street's... 
    Via StockStory
    < Previous 1 2 3 4 5 6 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.